NovaBay Pharmaceuticals to Hold Second Quarter 2022 Conference Call on August 11

Rhea-AI Summary

NovaBay Pharmaceuticals (NBY) will announce its financial results for the six months ended June 30, 2022, on August 11, 2022, following market close. An investment community conference call is scheduled for the same day at 4:30 p.m. Eastern time, with options for pre-registration and dial-in access. A live webcast will also be available, along with a replay accessible until September 1, 2022. NovaBay focuses on problem-solving health solutions through its brands Avenova and DERMAdoctor, which address eye irritations and skincare issues, respectively.

Positive

• Scheduled financial results announcement for H1 2022 may improve market transparency.
• Potential for increased investor engagement through the scheduled conference call.

Negative

• None.

EMERYVILLE, Calif.--(BUSINESS WIRE)-- NovaBay^® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2022 after market close on Thursday, August 11, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.

Date/Time:		Thursday, August 11, 4:30 p.m. ET / 1:30 p.m. PT
Pre-Registration:		Participants can pre-register for the conference call here:
		Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
Dial In:		Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call:
		866-777-2509 from within the U.S.
		412-317-5413 from outside the U.S.

The live webcast of the conference call also will be available at http://novabay.com/investors/events. A replay of the call will be available beginning two hours after its completion through September 1, 2022 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 9678917. The webcast will also be archived at http://novabay.com/investors/events.

About NovaBay Pharmaceuticals, Inc:

NovaBay Pharmaceuticals, Inc. creates science-based, problem-solving, accessible solutions for improved well-being through its two brands, Avenova^® and DERMAdoctor^®. Avenova products are scientifically created and clinically proven to help patients and consumers with common eye irritations. DERMAdoctor products are premium dermatologist-developed skincare solutions sold through traditional domestic retailers, digital beauty channels and international distributors.

Socialize and Stay Informed on NovaBay’s Progress
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website

Avenova Purchasing Information
For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com
Avenova.com

DERMAdoctor Purchasing Information
For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20220804005129/en/

NovaBay Contact

Justin Hall

Chief Executive Officer and General Counsel

510-899-8800

jhall@novabay.com

Investor Contact

LHA Investor Relations

Jody Cain

310-691-7100

jcain@lhai.com

Source: NovaBay Pharmaceuticals, Inc.

FAQ

When will NovaBay Pharmaceuticals report its financial results for Q2 2022?

NovaBay Pharmaceuticals will report its financial results for the six months ended June 30, 2022, on August 11, 2022.

What time is the NovaBay Pharmaceuticals conference call on August 11, 2022?

The conference call will take place at 4:30 p.m. Eastern time on August 11, 2022.

How can I access the NovaBay Pharmaceuticals conference call?

You can access the call by pre-registering online or dialing in using provided phone numbers.

What products does NovaBay Pharmaceuticals focus on?

NovaBay Pharmaceuticals focuses on health solutions through its brands Avenova and DERMAdoctor, targeting eye irritations and skincare.